Gujarat Inject Kerala Ltd Plans Board Meeting to Approve Q2 Un-Audited Financial Results
Gujarat Inject Kerala Ltd has scheduled a Board meeting to review and approve the company's un-audited financial results for the quarter ended on June 30, 2026.The meeting of the Company's Board of Directors is set to take place on Wednesday, July 15, 2026. The primary focus of the board will be the consideration and approval of the Un-Audited Financial Results for the specified quarter.
In addition to reviewing the financials, the agenda includes taking on record the Reports issued by the Statutory Auditors. Members of the Board are also required to consider any other business that may receive permission from the Chairperson.
Murali Shivshankaran Nair, Managing Director of Gujarat Inject Kerala Ltd, is associated with the company in this capacity as the meeting was announced by him.
Stock Price Movement
Gujarat Inject Kerala Ltd. settled at ₹13.65 on Friday, edging higher after the shares posted a 1.87% gain. The stock moved throughout the trading session, reaching an intraday high of ₹14.05 but finding support near a low of ₹13.45.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.